Medtronic to acquire Companion Medical to expand diabetes business

By Akshay Kedari  Date: 2020-08-13

Medtronic to acquire Companion Medical to expand diabetes business

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical.

The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, which is the first US FDA-cleared smart insulin pen device combined with an optimized diabetes care app manufactured by the privately held company.

The introduction of the InPen to the Medtronic portfolio strengthens the company’s ability to provide a special and comprehensive service system, irrespective of how insulin is administered, to patients where they are in their progression through diabetes. 

Companion Medical's purchase builds on previous Medtronic acquisitions, including Nutrino and Klue, which form foundations for the construction of efficient algorithms that leverage the advanced data science and AI capabilities of the organization. 

Medtronic will collaborate through this new investment to further automate insights and dosing capacities to reduce affecting factors irrespective of the technology chosen for insulin transmission. Additionally, the deal assists Medtronic's plan extends to InPen's worldwide distribution.

Sources cite that the acquisition will be concluded within one to two months, provided all usual closing conditions are met. This is estimated that the deal would be favorable to, and accretive to, Medtronic's adjusted income per share during the current fiscal year. This will also follow the long-term financial benchmarks of Medtronic for acquisitions.

Sean Salmon, executive vice president and president of the Diabetes Group at Medtronic highlighted the firm's goal to find a trusted partner that offers support for an individual's preferences whether they want to stay on MDI, take on automated insulin or refrain from using their pump for some time. 

Highlighting the InPen, Sean said that the company is looking forward to expanding InPen's success by integrating it with smart algorithms to provide customized, constructive dosing guidance. This smart CGM machine can make people careless of diabetes and lead their own lives independently, he added.

Sean Saint, CEO, and co-founder of Companion Medical shared his excitement and stated that they are excited to bring together abilities and product offerings to support ever more diabetes-induced citizens around the globe.

Source Credit - https://www.businesswire.com/news/home/20200811005363/en/Bayer-Acquire-UK-Based-Biotech-KaNDy-Therapeutics-Ltd

About Author

Akshay Kedari     aeresearch.net

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Boeing expects European carriers to have 8,705 new airplanes by 2040

Boeing expects European carriers to have 8,705 new airplanes by 2040

By Akshay Kedari

Aerospace major Boeing is anticipating the European commercial aviation industry to need nearly 8,705 new airplanes by 2040. The requirement will be driven by the growing leisure travel market and focus towards replacing the current fleet with more f...

Facebook to drop staunch defensive stance to revamp its public image

Facebook to drop staunch defensive stance to revamp its public image

By Akshay Kedari

Facebook CEO Mark Zuckerberg has reportedly approved a new initiative named Project Amplify, which will consist of implementing various strategies to shed a positive light on the social media giant’s public image. The idea, which was conceived...

Shell intends to scale its Sustainable Aviation Fuel production by 2025

Shell intends to scale its Sustainable Aviation Fuel production by 2025

By Akshay Kedari

Multinational oil and gas company Royal Dutch Shell plc is reportedly planning to begin scaling the production of low carbon jet fuel by 2025, to promote the practice of greenhouse gas emission reduction among the world’s airlines. The oil gia...

Fintech firm Xendit becomes a unicorn following USD 150 million funding

Fintech firm Xendit becomes a unicorn following USD 150 million funding

By Akshay Kedari

Indonesian financial technology company Xendit has reportedly secured USD 150 million during a Series C funding round which was led by Tiger Global. Other investors that participated in the latest fundraising included Justin Kan’s Goat Capital,...

Samsung Biologics to participate in 2050 carbon-neutral initiative

Samsung Biologics to participate in 2050 carbon-neutral initiative

By Akshay Kedari

South Korean biotechnology firm Samsung Biologics recently revealed the signing of a Memorandum of Understanding (MoU) to join the ‘Frontier 1.5D initiative’ to devise a climate risk management model. The company is set to join the 2050 C...